Patent · US Active

Inhibitor of apoptosis protein (IAP) antagonists

US9546174B2 · kind B2 · utility

8Cited by
6References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 26, 2013
Grant dateJan 17, 2017
Priority date—
Expiry dateNov 26, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are compounds that modulate the activity of inhibitor of apoptosis proteins (IAPs), compositions comprising the compounds, and methods of using the compounds and compositions comprising the compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.